Colin Pawlowski
Overview
Explore the profile of Colin Pawlowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
528
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghosh P, Niesen M, Pawlowski C, Bandi H, Yoo U, Lenehan P, et al.
iScience
. 2024 Jul;
27(8):110406.
PMID: 39081289
Post-COVID-19 conditions (long COVID) has impacted many individuals, yet risk factors for this condition are poorly understood. This retrospective analysis of 88,943 COVID-19 patients at a multi-state US health system...
2.
Silvert E, Hester L, Ramudu E, Pawlowski C, Kranenburg B, Buadi F, et al.
Am J Hematol
. 2023 Jul;
98(9):E255-E258.
PMID: 37403432
No abstract available.
3.
Niesen M, Matson R, Puranik A, OHoro J, Pawlowski C, Vachon C, et al.
PNAS Nexus
. 2023 Jan;
1(2):pgac042.
PMID: 36713312
As of 2021 November 29, booster vaccination against SARS-CoV-2 infection has been recommended for all individuals aged 18 years and older in the United States. A key reason for this...
4.
Puranik A, Lenehan P, OHoro J, Pawlowski C, Virk A, Swift M, et al.
PNAS Nexus
. 2023 Jan;
1(2):pgac058.
PMID: 36713311
COVID-19 vaccines are effective, but breakthrough infections have been increasingly reported. We conducted a test-negative case-control study to assess the durability of protection against symptomatic infection after vaccination with mRNA-1273....
5.
Venkatakrishnan A, Anand P, Lenehan P, Ghosh P, Suratekar R, Silvert E, et al.
Sci Rep
. 2023 Jan;
13(1):257.
PMID: 36604461
The emergence of highly transmissible SARS-CoV-2 variants and vaccine breakthrough infections globally mandated the characterization of the immuno-evasive features of SARS-CoV-2. Here, we systematically analyzed 2.13 million SARS-CoV-2 genomes from...
6.
Ghosh P, Niesen M, Pawlowski C, Bandi H, Yoo U, Lenehan P, et al.
medRxiv
. 2022 Dec;
PMID: 36523407
Post-COVID-19 conditions, also known as "long COVID", has significantly impacted the lives of many individuals, but the risk factors for this condition are poorly understood. In this study, we performed...
7.
Pawlowski C, Silvert E, OHoro J, Lenehan P, Challener D, Gnass E, et al.
PNAS Nexus
. 2022 Jul;
1(3):pgac071.
PMID: 35860600
Case reports of patients infected with COVID-19 and influenza virus ("flurona") have raised questions around the prevalence and severity of coinfection. Using data from , and , we analyzed trends...
8.
Puranik A, Lenehan P, OHoro J, Pawlowski C, Niesen M, Virk A, et al.
PNAS Nexus
. 2022 Jul;
1(3):pgac082.
PMID: 35832867
COVID-19 vaccines are effective, but breakthrough infections have been increasingly reported. We conducted a test-negative case-control study to assess the durability of protection after full vaccination with BNT162b2 against polymerase...
9.
Niesen M, Pawlowski C, OHoro J, Challener D, Silvert E, Donadio G, et al.
JAMA Netw Open
. 2022 Apr;
5(4):e227038.
PMID: 35420661
Importance: Recent reports on waning of COVID-19 vaccine-induced immunity have led to the approval and rollout of additional doses and booster vaccinations. Individuals at increased risk of SARS-CoV-2 infection are...
10.
Corchado-Garcia J, Zemmour D, Hughes T, Bandi H, Cristea-Platon T, Lenehan P, et al.
JAMA Netw Open
. 2021 Nov;
4(11):e2132540.
PMID: 34726743
Importance: Continuous assessment of the effectiveness and safety of the US Food and Drug Administration-authorized SARS-CoV-2 vaccines is critical to amplify transparency, build public trust, and ultimately improve overall health...